SNCA and Parkinson disease: For example in PD with mono- or bi-allelic GBA mutations there is reduction or loss of glucocerebrosidase enzyme activity in the brain, most severe in the substantia nigra[35], associated with elevated alpha-synuclein deposition as measured by Western blot [35].